Topics
April 2014 | Editor's Message
A Bittersweet Sign Off
Rachel Renshaw, Editor-in-Chief
May 7, 2026
Oculis Secures FDA SPA Agreement for PIONEER-1 Phase 3 Trial of Privosegtor in Optic Neuritis
May 6, 2026
Neuvasq Highlights Data for Targeting Antibodies for Blood Retina Barrier Restoration at ARVO
Bayer Expands Ophthalmology Portfolio with Acquisition of Perfuse Therapeutics in Deal Worth Up to $2.45 Billion
May 5, 2026
Ametek Reichert Expands Tele-Optometry Capabilities with SightChek Integration into DigitalOptometrics Platform
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
